Literature DB >> 17804121

Synthesis, antimicrobial and anti-inflammatory activities of some 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing trichlorophenyl moiety.

Prakash Karegoudar1, D Jagdeesh Prasad, Mithun Ashok, Manjathuru Mahalinga, Boja Poojary, Bantwal Shivarama Holla.   

Abstract

The reaction of 2,3,5-trichlorobenzoic acid hydrazide with carbon disulfide and potassium hydroxide followed by treatment with hydrazine hydrate afforded 3-(2,3,5-trichlorophenyl)-4-amino-1,2,4-triazole-5-thione (6). Alternatively, this triazole was also synthesized by fusing 2,3,5-trichlorobenzoic acid with thiocarbohydrazide. Condensation of (6) with various aromatic carboxylic acids in the presence of phosphorous oxychloride or with phenacyl bromides afforded two series of fused heterocycles namely 6-(substituted aryl)-3-(2,3,5-trichlorophenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadizoles (7) and 6-(substituted aryl)-3-(2,3,5-trichlorophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines (8), respectively. The structures of these newly synthesized compounds are characterised by elemental analysis, IR, (1)H NMR and mass spectroscopic studies. All the synthesized compounds were screened for their antimicrobial and anti-inflammatory activities. Some of the compounds exhibited promising antimicrobial and anti-inflammatory activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804121     DOI: 10.1016/j.ejmech.2007.06.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

1.  Novel ferrocenyl derivatives exert anti-cancer effect in human lung cancer cells in vitro via inducing G1-phase arrest and senescence.

Authors:  Ying Li; Han-lin Ma; Lei Han; Wei-yong Liu; Bao-xiang Zhao; Shang-li Zhang; Jun-ying Miao
Journal:  Acta Pharmacol Sin       Date:  2013-05-06       Impact factor: 6.150

2.  3-Ethyl-6-{1-[4-(2-methyl-prop-yl)phen-yl]eth-yl}-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.

Authors:  Hoong-Kun Fun; Samuel Robinson Jebas; K V Sujith; P S Patil; B Kalluraya
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-08-30

3.  2,2'-[(1,3,4-Thia-diazole-2,5-di-yl)bis-(sulfanedi-yl)]diaceto-nitrile.

Authors:  Joel T Mague; Mehmet Akkurt; Shaaban K Mohamed; Ahmed M M El-Saghier; Mustafa R Albayati
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-30

4.  Synthesis and antimicrobial activity of some novel fused heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazine derivatives.

Authors:  Jagdish K Sahu; Swastika Ganguly; Atul Kaushik
Journal:  J Adv Pharm Technol Res       Date:  2014-04

Review 5.  Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles.

Authors:  Bhawna Sharma; Amita Verma; Sunil Prajapati; Upendra Kumar Sharma
Journal:  Int J Med Chem       Date:  2013-04-30

6.  Synthesis and antibacterial activities of novel imidazo[2,1-b]-1,3,4-thiadiazoles.

Authors:  Kamal F M Atta; Omaima O M Farahat; Alaa Z A Ahmed; Mohamed G Marei
Journal:  Molecules       Date:  2011-06-28       Impact factor: 4.411

7.  Synthesis and electrophilic substitutions of novel pyrazolo[1,5-c]-1,2,4-triazolo[4,3-a]pyrimidines.

Authors:  Kamal F M Atta
Journal:  Molecules       Date:  2011-08-18       Impact factor: 4.411

8.  Synthesis and anti-inflammatory activity of new alkyl-substituted phthalimide 1H-1,2,3-triazole derivatives.

Authors:  Shalom Pôrto de Oliveira Assis; Moara Targino da Silva; Ronaldo Nascimento de Oliveira; Vera Lúcia de Menezes Lima
Journal:  ScientificWorldJournal       Date:  2012-12-05

9.  Pharmacologic Evaluation of Antidepressant Activity and Synthesis of 2-Morpholino-5-phenyl-6H-1,3,4-thiadiazine Hydrobromide.

Authors:  Alexey P Sarapultsev; Oleg N Chupakhin; Petr A Sarapultsev; Larisa P Sidorova; Tatiana A Tseitler
Journal:  Pharmaceuticals (Basel)       Date:  2016-05-19

Review 10.  Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction.

Authors:  Alexey P Sarapultsev; Pavel M Vassiliev; Petr A Sarapultsev; Oleg N Chupakhin; Laura R Ianalieva; Larisa P Sidorova
Journal:  Molecules       Date:  2018-07-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.